Olivopontocerebellar Atrophy

Olivopontocerebellar atrophy (OPCA) refers to neurodegeneration of the inferior olivary nucleus, pons, and the cerebellum, and is characterized by cerebellar ataxia and other neurological problems. Here is the latest research.

February 25, 2021

The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice.

Movement Disorders : Official Journal of the Movement Disorder Society
Atay VuralA Nazlı Başak
February 25, 2021

Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan.

Journal of Neurology
Rino InadaSusumu Kusunoki
February 25, 2021
Open Access

Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells.

PloS One
Richard J BurmanLeslie J Greenberg
February 23, 2021

Rapid Molecular Screen of Spinocerebellar Ataxia Types 1, 2, and 3 by Triplet-Primed PCR and Melting Curve Analysis.

The Journal of Molecular Diagnostics : JMD
Mulias LianSamuel S Chong
February 19, 2021
Open Access

Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7.

Movement Disorders : Official Journal of the Movement Disorder Society
Mehrdad A EstiarZiv Gan-Or
February 17, 2021
Open Access

Cathepsin K maintains the compartment of bone marrow T lymphocytes in vivo.

Immunity, Inflammation and Disease
Renate HausingerRobert A J Oostendorp
February 13, 2021
Open Access

V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations.

Neurology. Genetics
Martin PaucarPer Svenningsson
February 13, 2021
Open Access

Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.

Neurobiology of Disease
Júlia Canet-PonsGeorg Auburger
February 10, 2021
Open Access

Heterogeneity of murine periosteum progenitors involved in fracture healing.

ELife
Brya G MatthewsIvo Kalajzic
February 9, 2021
Open Access

Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1.

JCI Insight
Larissa NitschkeHuda Y Zoghbi
February 7, 2021

Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients.

Movement Disorders : Official Journal of the Movement Disorder Society
Luis E Almaguer-MederosGeorg Auburger
February 6, 2021
Open Access

The electrophysiological footprint of CACNA1A disorders.

Journal of Neurology
Elisabetta IndelicatoSylvia Boesch
February 6, 2021
Open Access

Secreted factors from mouse embryonic fibroblasts maintain repopulating function of single cultured hematopoietic stem cells.

Haematologica
Sandra Romero MarquezRobert A J Oostendorp
February 3, 2021

Tmem100- and Acta2-lineage Cells Contribute to Implant Osseointegration in a Mouse Model.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Alexander VespreyUgur M Ayturk
February 1, 2021
Open Access

Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease.

Neurobiology of Disease
Joana Pereira-SousaAndreia Teixeira-Castro

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/olivopontocerebellar-atrophy/80b59296-4932-4d18-b4f2-b547423b36d8